Contineum Therapeutics annual revenue
2023
2024
Contineum Therapeutics Revenue Growth & History (CTNM)
Contineum Therapeutics reported $0 in revenue for fiscal 2024, a decrease of 100.00% from the previous fiscal year.
View full Contineum Therapeutics company overviewContineum Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | −$50.0M | −100.00% |
| 2023 | 2023-12-31 | $50.0M | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Contineum Therapeutics filings at SEC.gov ↗